Vaccine Development and Collaborations: Lessons from the History of the Meningococcal A Vaccine (1969-73)

被引:4
|
作者
Baylac-Paouly, Baptiste [1 ,2 ]
机构
[1] Univ Claude Bernard Lyon 1, Univ Lyon, S2HEP, EA 4148, Villeurbanne, France
[2] S2HEP, BailmentLa Pagode 38 Blvd Niels Bohr,Campus DOUA, F-69622 Villeurbanne, France
关键词
Cerebrospinal meningitis A; Institut Merieux; World Health Organization; Collaborations; Meningococcal vaccine; Africa; SEROGROUP;
D O I
10.1017/mdh.2019.43
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Based on a wide range of historical sources, including published scientific literature and archives (Institut Merieux, WHO and IMTSSA), this article examines the history of the development of the meningococcal A vaccine between 1969 and 1973. It explores the social factors of vaccine development including various collaborations, informal discussions, the circulation of products and materials, formal meetings, trials and setbacks to highlight the complex reality of the development, production and use of the vaccine. Inscribed in a 'Golden Age' of vaccine development and production, this episode not only adds to the scholarship on the history of vaccines, which has tended to focus on a narrative of progress, but also considers the sharing of knowledge through collaborations, and the risks involved in the development of a vaccine. Finally, this perspective reveals the uncertainties and difficulties underlying the production of an effective vaccine.
引用
下载
收藏
页码:435 / 453
页数:19
相关论文
共 50 条
  • [21] Development of a group A meningococcal conjugate vaccine, MenAfriVac™
    Frasch, Carl E.
    Preziosi, Marie-Pierre
    LaForce, F. Marc
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (06) : 715 - 724
  • [22] BLV: lessons on vaccine development
    Abdala, Alejandro
    Alvarez, Irene
    Brossel, Helene
    Calvinho, Luis
    Carignano, Hugo
    Franco, Lautaro
    Gazon, Helene
    Gillissen, Christelle
    Hamaidia, Malik
    Hoyos, Clotilde
    Jacques, Jean-Rock
    Joris, Thomas
    Laval, Florent
    Petersen, Marcos
    Porquet, Florent
    Porta, Natalia
    Ruiz, Vanesa
    Safari, Roghaiyeh
    Suarez Archilla, Guillermo
    Trono, Karina
    Willems, Luc
    RETROVIROLOGY, 2019, 16 (01)
  • [23] Progress in meningococcal conjugate vaccine development and use
    Weiss, Adam
    Ellis, Ronald
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1243 - 1244
  • [24] VOLUNTARY DISCLOSURE CREDIBILITY AND SECURITIES PRICES - EVIDENCE FROM MANAGEMENT EARNINGS FORECASTS, 1969-73
    POWNALL, G
    WAYMIRE, G
    JOURNAL OF ACCOUNTING RESEARCH, 1989, 27 (02) : 227 - 245
  • [25] MENINGOCOCCAL INFECTIONS - .2. FIELD TRIAL OF GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE IN 1969-70
    GOLD, R
    ARTENSTEIN, MS
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1971, 45 (03) : 279 - +
  • [26] Challenges and progress in the development of a serogroup B meningococcal vaccine
    Lewis, Susan
    Sadarangani, Manish
    Hoe, J. Claire
    Pollard, Andrew J.
    EXPERT REVIEW OF VACCINES, 2009, 8 (06) : 729 - 745
  • [27] Lessons Learned Accelerate Vaccine Development
    Challener, Cynthia A.
    BIOPHARM INTERNATIONAL, 2016, 29 (04) : 38 - +
  • [28] Dengue vaccine development: lessons learnt from asymptomatic infections
    Sakuntabhai, A.
    Rouvinski, A.
    Dejnirattisai, W.
    Simon-Loriere, E.
    Mongkolsapaya, J.
    Screaton, G.
    Rey, F.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 37 - 37
  • [29] Development of a cytomegalovirus vaccine: lessons from recent clinical trials
    Gonczol, E
    Plotkin, S
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (03) : 401 - 412
  • [30] Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
    Ruckwardt, Tracy J.
    Morabito, Kaitlyn M.
    Graham, Barney S.
    IMMUNITY, 2019, 51 (03) : 429 - 442